LMR Partners’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

LMR Partners’s Portfolio TDACW Stock Details TDACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Buy	755,000 +355,000	+89%	+$356K	﹤0.01%	1039
2026 Q1	$48K	Hold	400,000	–	–	﹤0.01%	1311
2025 Q4	$124K	Hold	400,000	–	–	﹤0.01%	1325
2025 Q3	$116K	Hold	400,000	–	–	﹤0.01%	1270
2025 Q2	$100K	Hold	400,000	–	–	﹤0.01%	1175
2025 Q1	$80K	Buy	+400,000	New	+$70.4K	﹤0.01%	1165

Other funds holding TDACW

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LMR Partners's TDACW Position: Q2 2026 in Review

LMR Partners increased its Translational Development Acquisition Corp Warrants (TDACW) stake by 89% in Q2 2026, buying an estimated $356K and bringing the position to 755,000 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

LMR Partners first reported a position in TDACW in Q1 2025 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

LMR Partners held 755,000 shares of Translational Development Acquisition Corp Warrants worth $1.08M as of Q2 2026.
LMR Partners bought 355,000 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $356K.
Translational Development Acquisition Corp Warrants made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1039 holding.
LMR Partners first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 6 quarters since.
28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.